Risks and causes of acute myeloid leukaemia (AML)

We don’t know what causes most cases of acute myeloid leukaemia (AML). But there are some factors that may increase your risk of developing it. Some of these include being older, smoking and ionising radiation.

What is a risk factor?

Anything that can increase your risk of getting a disease is called a risk factor. 

Different cancers have different risk factors. Having one or more of these risk factors doesn't mean you will definitely get that cancer. 

Age

AML is more common in older people. The risk of AML increases from around 50 years and is greatest in those aged between 85 and 89 years.

Smoking

Smoking cigarettes can increase your risk of developing AML. There is benzene in cigarette smoke and this is likely to be a significant cause.

The risk of AML increases with the more cigarettes you smoke daily and the number of years you smoke.

Ionising radiation

We’ve known for a long time that exposure to high energy (ionising) radiation increases acute leukaemia risk. AML is one type of acute leukaemia.

For example, people who have had radiotherapy for cancer have an increased risk of acute leukaemia. This is because radiotherapy exposes you to a higher than normal level of radiation. But this risk is very small compared to the risk to your health of not treating the cancer.

Exposure to benzene at work

Exposure to the chemical benzene at work over a long time increases the risk of developing acute leukaemia. Workplaces where exposure is possible include:

  • oil refineries
  • chemical and petrochemical plants
  • pharmaceutical industry
  • rubber industry
  • shoe production
  • printing industry
  • rubber industry

In the UK, employers in these industries are required to prevent or control exposure to benzene as much as possible. 

Inherited conditions

Certain rare, inherited conditions can increase the risk of developing acute myeloid leukaemia. Some of these include:

  • Fanconi anaemia
  • Bloom syndrome
  • Li Fraumeni syndrome

Children with Down’s syndrome are more likely to get acute myeloid leukaemia than other children.

Past chemotherapy

People who have had treatment for Hodgkin lymphoma or breast cancer with particular chemotherapy drugs (such as chlorambucil, melphalan or cyclophosphamide) have a slightly increased risk of developing blood changes. These changes can lead to AML many years later. The amount of risk depends on how much treatment you had.

In the 10 years after treatment, survivors of childhood cancer have a higher risk of developing leukaemia than other people. But it is important to remember that this risk is still small compared to the risk to their health if the cancer wasn't treated. The risk also gets lower as time passes since the treatment.

Blood disorders

Some types of blood disorder make you more likely to get leukaemia than people without those blood disorders. These include

  • myelodysplastic syndrome
  • myeloproliferative neoplasms such as polycythaemia rubra vera (PCV) and chronic myeloid leukaemia (CML)
  • chronic myelomonocytic leukaemia (CMML) 

People with these disorders still only have a small risk of developing AML.

Autoimmune conditions

Autoimmune disorders are diseases caused by the body producing an immune response against its own tissues. Research has found that people with particular immune disorders have an increased risk of AML. 

The conditions include

  • rheumatoid arthritis
  • autoimmune haemolytic anaemia
  • ulcerative colitis

The amount that the risk increases depends on the condition you have. It is not known whether the increase in risk of AML is due to the autoimmune conditions or the drugs used to treat them.

Other possible causes

There are often stories about potential causes in the media. It isn’t always clear which ideas are supported by evidence. There might be things you have heard of that we haven’t included here. This is because either there is no evidence about them or it is less clear.

Reducing your risk

There are ways you can reduce your risk of cancer.

  • List of Classifications by cancer sites with sufficient or limited evidence in humans, IARC Monographs Volumes 1 to 134*
    The Internal Agency for Research on Cancer (IARC), last updated July 2023
    Accessed October 2023

  • The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017
    M Yi and others
    Journal of Hematology and Oncology, June 2020. Volume 13, Number 72

  • The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
    K Brown and others
    British Journal of Cancer, 2018. Volume 118, Pages 1130 to 1141

  • Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic malignancies, cytogenetic abnormalities, and WHO category
    J Kumar and others
    Human Pathology, May 2023. Volume 135, Pages 45 to 53

  • Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood
    M P Little and others
    British Journal of Cancer, August 2023. Volume 129, Pages 1152 to 1165

  • The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. If you need additional references for this information please contact patientinformation@cancer.org.uk with details of the particular risk or cause you are interested in. 

Last reviewed: 
01 Nov 2023
Next review due: 
01 Nov 2026

Related links